News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Theodoros Kontoulis: Heterogeneity of residual disease (RD) after NACT in breast cancer
Photo of Theodoros Kontoulis taken from klinikiagiosloukas.gr
Sep 23, 2024, 09:00

Theodoros Kontoulis: Heterogeneity of residual disease (RD) after NACT in breast cancer

Theodoros Kontoulis shared on LinkedIn:

“Most viewed in the last 7 days from JAMA Oncology: This Review analyzes the heterogeneity of residual disease (RD) after NACT in breast cancer.

Uncovering the anatomic and biological intricacies of RD will allow for increased precision in postneoadjuvant treatments, moving beyond the binary paradigm of RD vs pCR, toward more tailored adjuvant therapies.”

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer: A Review | JAMA Oncology

Authors: Paolo Tarantino, Gabriel Hortobagyi, Sara M. Tolaney, Elizabeth A. Mittendorf,

Theodoros Kontoulis

Source: Theodoros Kontoulis/LinkedIn

Theodoros Kontoulis is a Consultant Oncoplastic Breast Surgeon at Genesis Obstetrics Gynecology Surgery Hospital and St. Luke’s Hospital Thessaloniki. Previously, he was a Locum Consultant Breast Surgeon at Guy’s and St Thomas’ NHS Foundation Trust.

Breast Cancer cancer Elizabeth A. Mittendorf Gabriel Hortobagyi JAMA Oncology OncoDaily Oncology Paolo Tarantino Sara M. Tolaney Theodoros Kontoulis
Special Coverage
Insight
Jan 15, 2025, 17:38
Baris Turkbey: Impact of Endorectal Coil Use on Extraprostatic Extension Detection in Prostate MRI
Blog
Jan 15, 2025, 17:37
Shalini Rao: Delighted to chair the Gordon Research Seminar on Pancreatic Diseases in Maine
Insight
Jan 15, 2025, 17:27
Integration of Generative AI into Radiation Therapy practice
Insight
Jan 15, 2025, 17:26
Ajay Major: Summary table of all studies of CAR-T in CNS lymphomas
Insight
Jan 15, 2025, 17:19
Yakup Ergün: A Perspective on the MARS2 Trial by Eric Lim et al
Blog
Jan 15, 2025, 17:18
Registration is open for the Research Updates and Advances in Brain Mets webinar - Dana-Farber’s Breast Oncology Center
Insight
Jan 15, 2025, 17:14
Elias Orouji: A comprehensive review of the application of CAR-T cell therapy in colorectal cancer
Blog
Jan 15, 2025, 16:55
The Hong Kong International Oncology Forum 2025 - International Society of Liquid Biopsy
Opinion
Jan 15, 2025, 16:42
New AI Tool Predicts Immunotherapy Response Using Blood Tests - Memorial Sloan Kettering Cancer Center
Career
Jan 15, 2025, 16:39
William A. Hall was appointed chair of radiation oncology at the Medical College of Wisconsin
Blog
Jan 15, 2025, 16:37
Survivorship webinar by SIOP International - Childhood Cancer International
Blog
Jan 15, 2025, 16:31
An excerpt from the just-concluded Conversations on Cancer panel discussion - FDA Oncology